Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Zenith Capital Corporation

Healthcare CA ZENI.P

0.06CAD
0.00(0%)

Last update at 2026-06-19T13:30:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.100.14
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap16.00M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Income before tax -13.09600M -7.76800M -6.88000M -9.57800M -11.30100M
Minority interest - - - - -
Net income -13.12000M -7.79700M -6.91300M -9.63000M -11.32700M
Selling general administrative 2.83M 3.33M 2.07M 2.18M 2.79M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 0.20M 0.19M 0.19M 0.22M 0.29M
Ebit - -0.12337M -0.02900M -0.07435M -0.25259M
Ebitda -12.60300M -7.30700M -6.57300M -9.35100M -10.87200M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -11.16400M -7.37800M -6.67000M -10.34300M -11.15800M
Other operating expenses - - - - -
Interest expense 0.29M 0.27M 0.12M 0.01000M 0.00000M
Tax provision 0.02M 0.03M 0.03M 0.05M 0.03M
Interest income - - 0.10M - 0.01M
Net interest income -0.71500M -0.50700M -0.01500M -0.11000M 0.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 11.16M 7.38M 6.67M 10.34M 11.16M
Cost of revenue - - - - -
Total other income expense net -1.21700M 0.12M -0.19500M 0.88M -0.15600M
Discontinued operations - - - - -
Net income from continuing ops -13.12000M -7.79700M -6.91300M -9.63000M -11.32700M
Net income applicable to common shares - -0.14488M -0.04261M -0.08783M -0.26504M
Preferred stock and other adjustments - - - - -
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Total assets 3.17M 2.88M 3.33M 3.40M 3.92M
Intangible assets 1.00M 0.88M 0.78M 0.59M 1.34M
Earning assets - - - - -
Other current assets 0.06M 0.01M 0.29M 0.05M 0.03M
Total liab 18.03M 16.72M 13.73M 14.16M 7.69M
Total stockholder equity -14.85900M -13.83900M -10.39700M -10.75700M -3.77200M
Deferred long term liab - - - - -
Other current liab 0.18M 0.08M 0.26M 0.50M 0.92M
Common stock - 0.34M 0.33M 0.27M 0.15M
Capital stock 89.62M 80.94M 80.08M 75.64M 73.75M
Retained earnings -118.36000M -0.38575M -0.24087M -0.19826M -0.11043M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.03M 0.00800M 0.00700M 0.21M 0.21M
Cash and equivalents - - - - -
Total current liabilities 6.68M 0.00567M 0.00293M 0.00320M 0.00031M
Current deferred revenue - - - - -
Net debt 4.40M 3.47M 2.65M 0.38M -
Short term debt - - - - -
Short long term debt 4.43M 3.48M 2.65M 0.59M -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets 1.38M 0.08M 0.21M 0.22M 0.14M
Long term investments - - - - -
Net tangible assets - 0.07M 0.21M 0.22M 0.14M
Short term investments - - - - -
Net receivables - 0.00528M 0.00094M 0.00184M 0.00046M
Long term debt - - - - -
Inventory 0.11M 0.30M 0.63M 0.40M 0.38M
Accounts payable 2.07M 0.00567M 0.00293M 0.00320M 0.00031M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.70M 0.76M 0.55M 0.82M 0.32M
Deferred long term asset charges - - - - -
Non current assets total 1.79M 1.88M 1.69M 2.40M 2.29M
Capital lease obligations - - - 0.50M 0.92M
Long term debt total - - - - -
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Investments -0.17400M -0.25600M -0.24900M -0.37100M -0.35200M
Change to liabilities - 0.00274M -0.00026M 0.00288M 0.00075M
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities 9.28M 0.00904M 0.03M 0.15M 0.36M
Change to operating activities - - - - -0.03600M
Net income -13.12000M -0.14488M -0.04261M -0.08783M -0.26504M
Change in cash 0.02M -0.13745M -0.01197M 0.10M 0.30M
Begin period cash flow 0.00800M 0.00700M 0.21M 0.21M 1.16M
End period cash flow 0.03M 0.00800M 0.00700M 0.21M 0.21M
Total cash from operating activities -9.08400M -0.14649M -0.04197M -0.05412M -0.06140M
Issuance of capital stock 8.11M 0.48M 5.45M 2.50M 4.84M
Depreciation 0.20M 0.19M 0.19M 0.22M 0.29M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M -
Change to inventory 0.26M 0.30M 0.04M -0.00400M -0.32800M
Change to account receivables - -0.00434M 0.00090M -0.00137M -0.00111M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - - - 0.03M 0.24M
Capital expenditures 0.19M 0.16M 0.32M 0.32M 0.43M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.02900M 3.97M -2.35900M 6.49M 4.24M
Stock based compensation 1.84M 2.33M 1.01M 0.55M 1.17M
Other non cash items 2.06M 0.34M 0.07M -1.37200M 0.14M
Free cash flow -9.27600M -1.00900M -8.24600M -3.05000M -5.94100M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
ZENI-P
Zenith Capital Corporation		 - -% 0.06 - - - - -1.2929
SHRX
Sharp Therapeutics Corp.		 - -% 1.00 - - - 32.37
NRX
NurExone Biologic Inc.		 -0.01 1.79% 0.55 - 6.90 - 15.26 -7.2365
MIR
MedMira Inc		 - -% 0.07 - - 223.37 - 293.42 -80.0318
TTI
Thiogenesis Therapeutics Corp.		 - -% 0.56 - - - 15.17 -58.1577

Reports Covered

Stock Research & News

View All

Profile

Zenith Capital Corporation does not have significant operations. The company intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. Zenith Capital Corporation was incorporated in 2019 and is headquartered in Vancouver, Canada.

Zenith Capital Corporation

400 ? 725 Granville Street, Vancouver, BC, Canada, V7Y 1G5

Key Executives

Name Title Year Born
Mr. Charalambos Katevatis Pres, CEO, CFO, Corp. Sec. & Director 1942

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.